Swiss Go Trial Group

This Swiss study is testing whether personalized treatment recommendations can help patients with a hard-to-treat type of ovarian cancer. Researchers will analyze each patient's tumor and have a specialized board suggest treatments, which doctors and patients can then choose to f…

This large Phase 3 trial is testing whether adding the drug letrozole to standard maintenance therapy helps prevent ovarian cancer from coming back. It will involve 540 women with ER-positive ovarian, fallopian tube, or peritoneal cancer who have completed initial surgery and che…

This study aims to understand the connection between specific signs of adenomyosis seen on an ultrasound and the severity of symptoms like pain and heavy bleeding. It will enroll 1000 pre- and perimenopausal women, both with and without symptoms, who are already scheduled for a r…